HUTCHMED (China) Limited
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0 GBP
30.28 M GBP
505.78 M GBP
500.31 M
About HUTCHMED (China) Limited
Sector
Industry
CEO
Chig Fung Cheng
Website
Headquarters
Hong Kong
Founded
2000
Identifiers
3
ISINKYG4672N1198
HUTCHMED (China) Ltd. is a holding company, which engages in the research and development, manufacture, and sale of pharmaceuticals and health-oriented consumer products. It operates through the Oncology/Immunology and Other Ventures segments. The Oncology/Immunology segment includes the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The Other Ventures segment involves the other commercial businesses which include the sales, marketing, manufacture, and distribution of prescription drugs and healthcare products. The company was founded on December 18, 2000 and is headquartered in Hong Kong.
Related stocks
HCM Learning experiencePlaying Trading Simulator:
Big time rookie mistake.
Bought 350 shares at $41.71 on 3JAN18. Price was falling.
Same day bought 500 shares at $39.93 in order to dilute my buying price.
I began studying the chart and saw my mistake.
On 5JAN18 I sold my shares using a trailing stop of 10 cents.
It exe
Tracking HCMI've been a long term holder of HCM since 2009. They are also listed on the FTSE AIM 100 LSE:HCM.
They have outperformed the NASDAQ BIOTECHNOLOGY INDEX INDEX:NBI
Now would be a good place to exit.
I will continue to hold for now, i am not trading this. It's included in my long term portfolio.
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
513120
GF CSI Hong Kong Brand Name Drug Exchange Traded Fund UnitsWeight
1.67%
Market value
31.68 M
USD
159892
ChinaAMC Hang Seng Hong Kong-Listed Biotech Index ETF Units AWeight
1.24%
Market value
7.86 M
USD
159567
Yinhua China Sec Hong Kong Stock Connect Innovative Drug EtfWeight
1.58%
Market value
6.54 M
USD
513200
E Fund CSI HK Connect Health Care Composite Exchange Traded Fund UnitsWeight
1.24%
Market value
3.94 M
USD
513780
INVESCO Great Wall CSI Hong Kong Connect Innovative Drug Exchange Traded Fund UnitsWeight
1.67%
Market value
2.57 M
USD
Explore more ETFs
Frequently Asked Questions
The current price of HCM is 199 GBX — it has decreased by −2.45% in the past 24 hours. Watch HUTCHMED (China) Limited stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange HUTCHMED (China) Limited stocks are traded under the ticker HCM.
HCM stock has risen by 0.51% compared to the previous week, the month change is a −9.95% fall, over the last year HUTCHMED (China) Limited has showed a −14.72% decrease.
We've gathered analysts' opinions on HUTCHMED (China) Limited future price: according to them, HCM price has a max estimate of 480.59 GBX and a min estimate of 206.85 GBX. Watch HCM chart and read a more detailed HUTCHMED (China) Limited stock forecast: see what analysts think of HUTCHMED (China) Limited and suggest that you do with its stocks.
HCM stock is 2.51% volatile and has beta coefficient of 0.93. Track HUTCHMED (China) Limited stock price on the chart and check out the list of the most volatile stocks — is HUTCHMED (China) Limited there?
Today HUTCHMED (China) Limited has the market capitalization of 1.74 B, it has decreased by −5.52% over the last week.
Yes, you can track HUTCHMED (China) Limited financials in yearly and quarterly reports right on TradingView.
HUTCHMED (China) Limited is going to release the next earnings report on Feb 26, 2026. Keep track of upcoming events with our Earnings Calendar.
HCM earnings for the last half-year are 0.38 GBX per share, whereas the estimation was 0.21 GBX, resulting in a 78.49% surprise. The estimated earnings for the next half-year are 0.37 GBX per share. See more details about HUTCHMED (China) Limited earnings.
HUTCHMED (China) Limited revenue for the last half-year amounts to 202.29 M GBX, despite the estimated figure of 240.67 M GBX. In the next half-year revenue is expected to reach 228.31 M GBX.
HCM net income for the last half-year is 328.89 M GBP, while the previous report showed 9.55 M GBP of net income which accounts for 3.34 K% change. Track more HUTCHMED (China) Limited financial stats to get the full picture.
No, HCM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 21, 2025, the company has 1.81 K employees. See our rating of the largest employees — is HUTCHMED (China) Limited on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HUTCHMED (China) Limited EBITDA is −5.41 M GBP, and current EBITDA margin is −5.18%. See more stats in HUTCHMED (China) Limited financial statements.
Like other stocks, HCM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HUTCHMED (China) Limited stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HUTCHMED (China) Limited technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HUTCHMED (China) Limited stock shows the strong sell signal. See more of HUTCHMED (China) Limited technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.